FDA budget execution and control support

Active Awarded Last action

Contract number
75F40123F19006
Awardee
Awarding agency
Obligated
$24,329,855

Award facts

Opportunity
  • 75F40122Q00129 Solicitation number
Contract value 95% obligated
  • $25,207,267.11 Current, with exercised options
  • $25,701,176.63 Potential, with all options
Completion date 81% complete
Current and potential, with all options
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Calverton, MD 20705, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00017 · FDA budget execution and control support, beti process improvement, and travel operations - EO 14398 $3,826,333
Funding Only Action P00016 · EO 14398 - FDA budget execution and control support, beti process improvement, and travel operations $3,357,334
Funding Only Action P00015 $1,455,196
Funding Only Action P00014 $1,676,395
Other Administrative Action P00012 $0
Other Administrative Action P00011 $1,117,555
Other Administrative Action P00010 · Beti process improvement and travel operations $5,799,123
Other Administrative Action P00009 · DE-obligate funds -$1,117,555
Terminate for Convenience P00008 · EOI::radical transparency about wasteful spending (february 18, 2025) EOI::bilateral modification partial termination -$370,723
Other Administrative Action P00007 $0
Exercise an Option P00006 · The purpose of modification is to 1) modify option year 2; and 2) exercise the modified option year 2. $2,934,439
Other Administrative Action P00005 · The purpose of this modification is to add subsection 2.2.2.3 training plan module 1: which applies to option year 1. $259,483
Funding Only Action P00004 $949,178
Exercise an Option P00003 $1,599,859
Funding Only Action P00001 $84,689
Funding Only Action P00002 $962,101
Original award $1,796,447
Show all 17

About this award

Written by GovTribe AI ·

The Food and Drug Administration issued a BPA call to Deloitte Consulting LLP on December 8, 2022 with a ceiling value of $25.7 million under the Multiple Award Schedule (MAS). The call supports FDA budget execution and control, BETI process improvement, and travel operations per Executive Order 14398, with ultimate completion by September 28, 2027. Work is performed in Calverton, Maryland. The engagement is priced on a labor-hours basis. In FY2025, Deloitte deployed 7.6 FTEs across 15,861 contractor hours at a derived government-paid rate of $199.06 per hour, with 32% of hours subcontracted to two vendors. Year-over-year, Deloitte invoiced $1.5 million in FY2023 (5.0 FTEs, 10,315 hours at $142.11/hr), $2.6 million in FY2024 (8.8 FTEs, 18,414 hours at $141.37/hr), and $3.2 million in FY2025, reflecting rising labor rates and variable staffing depth.

Quick answers

Who was awarded contract 75F40123F19006?

75F40123F19006 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on December 8, 2022.

How much is contract 75F40123F19006 worth?

The government has obligated $24,329,855 on 75F40123F19006. Its current value, with exercised options, is $25,207,267. Its potential value, with all options, is $25,701,177.

Is contract 75F40123F19006 an order under another contract?

Yes. 75F40123F19006 is a BPA call under 47QRAA18D001P-75F40121A00003, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40123F19006 competed?

The extent of competition for 75F40123F19006 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login